The Cardiologist's PCSK9 Script: 6 Months of Frustration -The 'honestly ridiculous' process William O'Neill, MD, faced for his own Rx
When PCSK9 inhibitors first came on the scene for lipid lowering, interventional cardiologist William O'Neill, MD, medical director of the Center for Structural Heart Disease at Detroit's Henry Ford Hospital, jumped right in -- as a patient.